PapRIV
Based on 3 publication(s) in Google Scholar
PapRIV is an agonist of BV-2 microglial cells, capable of activating microglial cells through an NF-κB-dependent pathway. PapRIV induces the expression of pro-inflammatory cytokines such as IL-6 and TNFα and increases the production of reactive oxygen species (ROS). PapRIV can cross the blood-brain barrier.
For research use only. We do not sell to patients.
- Formula: C38H53N9O13
- Molecular Weight:843.88
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) PapRIV
More
Biological Activity
Chemical Information
-
Molecular Weight 843.88
-
Formula C38H53N9O13
-
Sequence
Ser-Asp-Leu-Pro-Phe-Glu-His
-
Sequence Shortening
SDLPFEH
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
CNS Neurosci Ther
Cycloastragenol Derivatives Improve Tyrosine Metabolism, Regulate TLR4/NF-κB/TERT Signaling Pathways, and Inhibit MPTP Induced Neuroinflammation and PD Symptoms. [Abstract]2026 Feb;32(2):e70787. PMID: 41670296 -
CNS Neurosci Ther
Neuroprotective Effects of Transcranial Pulsed Current Stimulation: Modulation of Microglial Polarization in Traumatic Brain Injury. [Abstract]2025 Sep;31(9):e70606. PMID: 40916543 -
Cardiovasc Toxicol
Chronic Anatabine Administration Attenuates Cardiovascular Activity by Targeting NF-κB/NLRP3/Caspase-1-Dependent Pyroptosis and Oxidative Stress in Paraventricular Nucleus of Hypertensive Rat. [Abstract]2025 Sep;25(9):1352-1368. PMID: 40690148
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)